• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by
the American Heart Association in response to the high prevalence of metabolic and kidney …

Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Social determinants of health (SDoH), which encompass the economic, social,
environmental, and psychosocial factors that influence health, play a significant role in the …

Structural racism has been and remains a fundamental cause of persistent health disparities
in the United States. The coronavirus disease 2019 (COVID-19) pandemic and the police …

This scientific statement summarizes the available preclinical, epidemiological, and clinical
trial evidence that supports the contributions of prepregnancy (and interpregnancy) …

SDOH affect CVD prevention efforts. The SDOH that affect cardiovascular risk factors,
diseases, and outcomes are complex and intersect. Addressing them can be challenging …

Cardiovascular diseases (CVDs) are the leading cause of death globally. Their prevalence
and mortality rates continue to rise. This narrative review explores well-known risk factors for …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Importance Cardiovascular-kidney-metabolic (CKM) syndrome—a novel, multistage,
multisystem disorder as defined by the American Heart Association—is highly prevalent in …